An Analysis of Inpatient Tobacco Use Treatment Transition to Telehealth. Issue 5 (21st December 2021)

• Record Type: Journal Article
• Authors: Shoenbill, Kimberly A; Newcomer, Eiman; Valcourt-Hall, Celeslie; Baca-Atlas, Michael H; Smith, Caleb A; Goldstein, Adam O
• Is Part Of: Nicotine & tobacco research. Volume 24:Issue 5(2022)
• Page Start: 794
• Page End: 798
• Publication Date: 2021-12-21
• Subjects: Nicotine -- Periodicals; Tobacco -- Research -- Periodicals; Tobacco habit -- Periodicals; Nicotine -- Periodicals; Tobacco -- Periodicals; Smoking -- Periodicals; 613.85
• DOI: 10.1093/ntr/ntab233
• Languages: English
• ISSNs: 1462-2203

Abstract

Abstract: Introduction: During the COVID-19 pandemic, many tobacco users increased their tobacco use, and calls to quitlines decreased. Among inpatients, the pandemic also necessitated a rapid transition of intensive tobacco use counseling to telehealth counseling. No data exist comparing the outcomes of telehealth inpatient counseling with in-person (pre-telehealth) counseling. Aims and Methods: We examined inpatient data from a large tobacco treatment program (TTP) during two comparable time periods 04/01/2019–09/30/2019 (pre-telehealth) and 04/01/2020–09/30/2020 (telehealth). The pre-telehealth and telehealth populations were compared using Pearson's chi-square test for homogeneity on each populations' patient, visit, and medication acceptance characteristics. Reach to "current tobacco users" was analyzed using TTP flowsheet and electronic health record (EHR) data in relation to aggregate EHR data in the data warehouse. Results: Mean monthly tobacco treatment inpatient counseling and outreach visits increased 38.9% in the telehealth period ( M = 376, SD = 36.7) compared with the pre-telehealth period ( M = 271, SD = 50.0) ( t (10) = 3.8, p = .004). Reach significantly increased from 32.8% to 65.9% among all "current tobacco users" admitted, including 31.8% to 66.6% in races at higher risk for COVID-19 severe disease. Pearson's chi-square tests for homogeneity showed significant differences in the pre-telehealth and telehealth population distributions for age, visit type, ethnicity, and medication acceptance. Conclusions: This study offers the first understanding of characteristics of patients, visits, and medication acceptances in pre-telehealth and telehealth tobacco use treatment for inpatient populations. Larger reach and counseling were identified in the telehealth population. This study's findings on inpatient tobacco use treatment can inform future reach and engagement of large numbers of patients who use tobacco products. Implications: This study provides the first analysis of inpatient tobacco use treatment transition to telehealth delivery of care during the COVID-19 pandemic. The transition resulted in increases in reach and cessation counseling. These findings can inform efforts to improve reach, engagement, and research on telehealth delivery of inpatient tobacco use treatment.